부산대학교 도서관

Background Nebulizers are commonly used to treat respiratory diseases, which are a major cause of morbidity and mortality. While inhalation therapy with antibodies has been evaluated in preclinical studies and clinical trials for respiratory diseases, it has not yet been approved for treatment. Moreover, there is limited information regarding the delivery efficiency of therapeutic antibodies via nebulizer. Methods In this study, the nebulization characteristics and drug delivery efficiencies were compared when immunoglobulin G (IgG) was delivered by five nebulizers using two airway models and five breathing patterns. The study confirmed that the delivered dose and drug delivery efficiency were reduced in the child model compared to those in the adult model and in the asthma pattern compared to those in the normal breathing pattern. Results The NE-SM1 NEPLUS vibrating mesh nebulizer demonstrated the highest delivery efficiency when calculated as a percentage of the loading dose, whereas the PARI BOY SX + LC SPRINT (breath-enhanced) jet nebulizer had the highest delivery efficiency when calculated as a percentage of the emitted dose. Conclusion The results suggest that the total inspiration volume, output rate, and particle size should be considered when IgG nebulization is used. We, therefore, propose a method for evaluating the efficiency of nebulizer for predicting antibody drug delivery. Keywords: Nebulizer, IgG, Drug delivery, Respiratory disease, Breathing simulator
Author(s): Soon Woo Hong[sup.1], Kyung Hwa Chang[sup.1], Chang Jae Woo[sup.1,4], Ho Chul Kim[sup.2], Bong Seop Kwak[sup.1], Bong Joo Park[sup.3] and Ki Chang Nam[sup.1] Introduction Nebulizers are typically used to manage [...]